Filter posts

GMO Answers on the IARC Assessment of 2,4-D as a Possible Carcinogen

The International Agency for Research on Cancer (IARC) creates Working Groups to periodically consider lifestyles, …

ASCO Publishes New "Value Framework" for Cancer Treatment Options

On Monday, the American Society of Clinical Oncology (ASCO) published “A Framework to Assess the …

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

The Intellectual Property Track at the BIO International Convention was a chance for IP thought …

FDA Acts on Biosimilars

The Biologics Price Competition and Innovation Act (BPCIA) deferred to the Food and Drug Administration …

Driving to Drive Women in Ag Business

On June 1 in Easton, ME, American Agri-Women (AAW) set out on a 5 month long drive …

Pope Francis' Encyclical Includes Ambivalent Remarks on Ag Biotech

On June 18, 2015, Pope Francis released on the Vatican website an encyclical letter that …